期刊文献+

原发性中枢神经系统非霍奇金淋巴瘤的影像学特征 被引量:4

Imaging features of primary non-Hodgkin's lymphoma of the central nervous system
下载PDF
导出
摘要 目的探讨原发性CNS非霍奇金淋巴瘤(PCNSNHL)的影像学特征。方法回顾性分析12例PCNSNHL患者的临床资料。结果本组患者MRI检查示T1等或低信号,T2等或高信号;占位病灶呈均匀团块样强化,周围水肿,且水肿范围与病变大小不成比例;占位病灶早期动态增强示T1低信号,T2高信号。5例患者行质子核磁共振光谱成像(1H-MRS)示强化区胆碱峰明显升高,N-乙酰天冬氨酸峰明显降低。结论PCNSNHL的MRI主要特征为T1增强出现"尖角征"、"脐凹征"征,或表现为不规则强化;1H-MRS表现为胆碱峰明显升高,N-乙酰天冬氨酸峰明显降低,甚至出现脂质峰。 Objective To explore the imaging features of patients with primary non-Hodgkin's lymphoma of the central nervous system (PCNSNHL). Methods Clinical data of 12 patients with PCNSNHL were analyzed retrospectively. Results MRI showed equal or lower signal on TIWI, and equal or higher signal on T2WI. The space-occupying lesion showed massive homogeneous enhancement and peripheral edema, and the range of edema was disproportionate to lesion size. The dynamic enhanced MRI of space-occupying lesion in early stage showed low signal on T1, high signal on T2. ^1H-magnetic resonance spectroscopy (^1H-MRS) of 5 cases showed choline (Cho) peak of enhanced regions was significantly increased, and N-acetyla spartate (NAA) peak of enhanced regions was significantly decreased. Conclusions MRI features of PCNSNHL are " sharp angle sign", " notch sign" on enhanced T1, or inhomogeneous enhancement. 1H-MRS shows choline (Cho) peak of enhanced regions is significantly increased, and N-acetyla spartate (NAA) peak of enhanced regions is significantly decreased, even has lipid peak.
出处 《临床神经病学杂志》 CAS 2018年第1期26-28,共3页 Journal of Clinical Neurology
关键词 原发性中枢神经系统淋巴瘤 弥漫性大B细胞型非霍奇金淋巴瘤 影像学特征 primary central nervous system lymphoma diffuse large B-cell non-Hodgkin's lymphoma imaging feature
  • 相关文献

参考文献6

二级参考文献84

  • 1倪新初,沈钧康,陆之安,钱农,潘昌杰,荣伟良,项剑波,陈建国,龚建平,钱铭辉.0.5TMR动态增强技术鉴别良性前列腺增生症与前列腺癌的研究[J].中国医学影像技术,2004,20(8):1168-1171. 被引量:4
  • 2胡小吾,洪波,王文仲,路红社.具有自行消失特征的原发性中枢神经系统淋巴瘤[J].中华放射学杂志,1994,28(8):563-564. 被引量:4
  • 3赖旭峰,刘红,丛振杰.颅内单发原发性恶性淋巴瘤的MRI诊断[J].医学影像学杂志,2005,15(5):367-369. 被引量:4
  • 4祁斌,应世红,赖旭峰,陈文辉,杨德琪.颅内单发原发性恶性淋巴瘤的MRI和CT表现[J].浙江临床医学,2006,8(12):1242-1243. 被引量:1
  • 5O'Connor JP, Jackson A, Parker GJ, et al. DCE MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer, 2007,96(2) :189-195.
  • 6Hoskin PJ, Carnell DM, Taylor NJ, et al. Hypoxia in prostate cancer : correlation of BOLD-MRI with pimonidazole immunohistochemistry. Int J Radiat Oncol Biol Phys, 2007,68(4) :1065-1071.
  • 7Hara N, Okuizumi M, Koike H, et al. Dynamic contrastenhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate, 2005,62(2) : 140-147.
  • 8Kozlowski P, Chang SD, Jones EC, et al. Combined diffusion weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--cor relation with biopsy and histopathology. J Magn Reson Imaging, 2006, 24(1):108- 113.
  • 9Ren J, Huan Y, Wang H, et al. Dynamic contrast enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis. Clin Radiol, 2008,63(2):153-159.
  • 10Yoshizako T, Wada A, Hayashi T, et al. Usefulness of diffusionweighted imaging and dynamic contrast enhanced magnetic reso nance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol, 2008,49(10):1207- 1213.

共引文献69

同被引文献34

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部